⚠️FOR RESEARCH PURPOSES ONLY
← Back to Research Database
ResearchPeptide

NAD+

Published Research

PubMed-indexed studies for NAD+

Research

Nicotinamide Adenine Dinucleotide (NAD) Metabolism as a Relevant Target in Cancer.

Cells 2022
View on PubMed →
Research

Nicotinamide adenine dinucleotide (NAD+): essential redox metabolite, co-substrate and an anti-cancer and anti-ageing therapeutic target.

Biochemical Society transactions 2020
View on PubMed →
Research

The Safety and Antiaging Effects of Nicotinamide Mononucleotide in Human Clinical Trials: an Update.

Advances in nutrition (Bethesda, Md.) 2023
View on PubMed →
Research

Novel Approach to Skin Anti-Aging: Boosting Pharmacological Effects of Exogenous Nicotinamide Adenine Dinucleotide (NAD(+)) by Synergistic Inhibition of CD38 Expression.

Cells 2024
View on PubMed →
Research

Nicotinamide Adenine Dinucleotide-Loaded Lubricated Hydrogel Microspheres with a Three-Pronged Approach Alleviate Age-Related Osteoarthritis.

ACS nano 2025
View on PubMed →
Research

Impaired nicotinamide adenine dinucleotide (NAD(+) ) metabolism in diabetes and diabetic tissues: Implications for nicotinamide-related compound treatment.

Journal of diabetes investigation 2020
View on PubMed →

Research-Grade NAD+

YPB.223
NAD+
Price range: $70.00 through $120.00
⚠️ For laboratory research only. Not for human use.